In focus · trending topic

Parkinsons Disease

58 stories · following the connections

Adamas Reports First Quarter 2018 Financial Results

By Nasdaq OMXMay 3, 2018, 8:06 PM UTC

Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

By Nasdaq OMXApr 19, 2018, 9:30 AM UTC

Adamas Announces Multiple Data Presentations at the American Academy of Neurology Annual Meeting

By Nasdaq OMXApr 12, 2018, 9:09 PM UTC

International Stem Cell Corporation Announces 2017 Fourth Quarter and Year-End Results

By Nasdaq OMXApr 10, 2018, 12:45 PM UTC

Adamas Announces Publication of Data Supporting the Benefits of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia

By Nasdaq OMXMar 15, 2018, 1:01 PM UTC

Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 14, 2018, 11:02 AM UTC

Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease

By Nasdaq OMXMar 9, 2018, 12:02 PM UTC

Adamas to Present at Two Upcoming Investor Conferences

By Nasdaq OMXMar 6, 2018, 7:35 PM UTC